Apathy: the democratic disease = L'apathie : une maladie démocratiqueGREEN, Jeffrey E.Philosophy & social criticism. 2004, Vol 30, Num 5-6, pp 745-768, issn 0191-4537, 24 p.Article

Genomic Approaches to the Study of Breast CancerGREEN, Jeffrey E.Breast disease. 2004, Vol 19, issn 0888-6008, 92 p.Serial Issue

MicroRNA regulation in cancer-associated fibroblastsAPRELIKOVA, Olga; GREEN, Jeffrey E.Cancer immunology and immunotherapy. 2012, Vol 61, Num 2, pp 231-237, issn 0340-7004, 7 p.Article

Genetic, genomic, and bioinformatic tools for studying breast cancer progressionHUNTER, Kent.Breast disease. 2004, Vol 19, pp 83-91, issn 0888-6008, 9 p.Article

Molecular mechanisms of breast cancer progression: Lessons from mouse mammary cancer models and gene expression profilingYUMEI YE; TING HU QIU; KAVANAUGH, Claudine et al.Breast disease. 2004, Vol 19, pp 69-82, issn 0888-6008, 14 p.Article

Genomic Analyses as a Guide to Target Identification and Preclinical Testing of Mouse Models of Breast CancerBENNETT, Christina N; GREEN, Jeffrey E.Toxicologic pathology. 2010, Vol 38, Num 1, pp 88-95, issn 0192-6233, 8 p.Article

Gene expression profiling in breast cancer researchMELTZER, Paul S.Breast disease. 2004, Vol 19, pp 23-27, issn 0888-6008, 5 p.Article

Expression profiling and breast cancer biologyMILLER, Lance; LIU, Edison T.Breast disease. 2004, Vol 19, pp 29-34, issn 0888-6008, 6 p.Article

Genomic approaches to identifying breast cancer susceptibility factorsSTRUEWING, Jeffery P.Breast disease. 2004, Vol 19, pp 3-9, issn 0888-6008, 7 p.Article

Integromic analysis of the NCI-60 cancer cell linesWEINSTEIN, John N.Breast disease. 2004, Vol 19, pp 11-22, issn 0888-6008, 12 p.Article

Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouseZHUOHUA WANG; PRINS, Gail S; COSCHIGANO, Karen T et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 12, pp 5188-5196, issn 0013-7227, 9 p.Article

Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM. CommentaryGREEN, Jeffrey E; CARDIFF, Robert; MATZKE, M. A et al.Transgenic research. 2002, Vol 11, Num 6, pp 635-638, issn 0962-8819, 4 p.Article

2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic miceGREEN, Jeffrey E; SHIBATA, Masa-Aki; SHIBATA, Eiko et al.Cancer research (Baltimore). 2001, Vol 61, Num 20, pp 7449-7455, issn 0008-5472Article

Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanismsHUDSON, Tamaro S; HARTLE, Diane K; HURSTING, Stephen D et al.Cancer research (Baltimore). 2007, Vol 67, Num 17, pp 8396-8405, issn 0008-5472, 10 p.Article

Bmi-1 Cooperates with H-Ras to Transform Human Mammary Epithelial Cells via Dysregulation of Multiple Growth-Regulatory PathwaysDATTA, Sonal; HOENERHOFF, Mark J; BOMMI, Prashant et al.Cancer research (Baltimore). 2007, Vol 67, Num 21, pp 10286-10295, issn 0008-5472, 10 p.Article

Molecular cytogenetics of mouse models of breast cancerRIED, Thomas; DORRITIE, Kathy; WEAVER, Zoë et al.Breast disease. 2004, Vol 19, pp 59-67, issn 0888-6008, 9 p.Article

Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesisHUDSON, Tamaro S; CARLSON, Bradley A; HOENEROFF, Mark J et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 6, pp 1225-1230, issn 0143-3334, 6 p.Article

Metastatic Growth from Dormant Cells Induced by a Col-I―Enriched Fibrotic EnvironmentBARKAN, Dalit; EL TOUNY, Lara H; GREEN, Jeffrey E et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 14, pp 5706-5716, issn 0008-5472, 11 p.Article

Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancerKAWAKUBO, Hirofumi; CAREY, Jennifer L; BRACHTEL, Elena et al.Oncogene (Basingstoke). 2004, Vol 23, Num 50, pp 8310-8319, issn 0950-9232, 10 p.Article

Large-scale transcriptional profiling of murine mammary developmentMASTER, Stephen R; CHODOSH, Lewis A.Breast disease. 2004, Vol 19, pp 47-57, issn 0888-6008, 11 p.Article

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumorsYIPING WU; CUI, Karen; MIYOSHI, Keiko et al.Cancer research (Baltimore). 2003, Vol 63, Num 15, pp 4384-4388, issn 0008-5472, 5 p.Article

The use of genetically altered mice for breast cancer prevention studiesKAVANAUGH, Claudine; GREEN, Jeffrey E.The Journal of nutrition. 2003, Vol 133, Num 7, pp 2404S-2409S, issn 0022-3166, SUPConference Paper

Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocationBING LIU; LIN LIU; TSYKIN, Anna et al.Bioinformatics (Oxford. Print). 2010, Vol 26, Num 24, pp 3105-3111, issn 1367-4803, 7 p.Article

Increased expression of VEGF₁₂₁/VEGF_165-189 ratio results in a significant enhancement of human prostate tumor angiogenesisCATENA, Raul; MUNIZ-MEDINA, Vanessa; MORALEJO, Beatriz et al.International journal of cancer. 2007, Vol 120, Num 10, pp 2096-2109, issn 0020-7136, 14 p.Article

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanismsHUH, Jung-Im; CALVO, Alfonso; STAFFORD, Jeffrey et al.Oncogene (Basingstoke). 2005, Vol 24, Num 5, pp 790-800, issn 0950-9232, 11 p.Article